Thinking of joining a study?

Register your interest

Become a volunteer?

NCT05874557 | Not yet recruiting | Hemodialysis Complication

A Study of Compound Amino Acid Capsule on Maintenance Hemodialysis Patients
Sponsor:

RenJi Hospital

Brief Summary:

The goal of this retrospective cohort study is to investigate the effects of compound amino acid capsule on nutrition, calcium and phosphorus metabolism in maintenance hemodialysis(MHD) patients. The main questions it aims to answer are: Can compound amino acid capsule improve the nutritional status of MHD patients? Can compound amino acid capsule help to correct the calcium and phosphorus metabolism imbalance of MHD patients? Is compound amino acid capsule safe for MHD patients? We will collect the medical history and laboratory data of MHD patients who regularly took compound amino acid capsule for 9 months or did not use the same preparation in previous medical experience. We focus on the difference of serum albumin level between the treatment group and the control group within 9 months, as well as prealbumin, hemoglobin, ferritin, calcium, phosphorus, 1,25-OH 2-D3 and intact parathyroid hormone (iPTH).

Condition or disease

Hemodialysis Complication

Study Type : Observational
Estimated Enrollment : 40 participants
Official Title : Effects of Compound Amino Acid Capsule on Nutrition, Calcium and Phosphorus Metabolism in Maintenance Hemodialysis Patients
Actual Study Start Date : June 2023
Estimated Primary Completion Date : July 2023
Estimated Study Completion Date : August 2023

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 80 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Patients who received maintenance hemodialysis (≥ 3 months) in Renji Hospital;
  • Regularly participate in the routine laboratory examination of the hemodialysis center every 3 months;
  • Inclusion criteria of the treatment group: regular treatment with compound amino acid capsule for 9 months (2 tablets, 3 times a day, orally);
  • Inclusion criteria of the control group: no compound amino acid capsules or similar nutritional supplement were taken.
Exclusion Criteria
  • Severe heart failure (NYHA III/IV);
  • Human immunodeficiency virus positive or is suffering from other serious infectious diseases;
  • Have a history of malignant tumor;
  • Women during pregnancy or lactation;
  • Exclusion criteria for treatment group: previous use of amino acids or compound ketoacid supplement
A Study of Compound Amino Acid Capsule on Maintenance Hemodialysis Patients

Location Details

Please Choose a site

A Study of Compound Amino Acid Capsule on Maintenance Hemodialysis Patients

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations